American Vanguard (AVD) Expected to Announce Quarterly Earnings on Monday

Key Points

• Q1 2026 earnings are expected before the market opens on Monday, May 11, with analysts forecasting EPS of ($0.06) and revenue of $120.00 million; the company's conference call is listed for Friday, June 5, 2026 at 9:00 AM ET.
• In the prior quarter (reported March 16) AVD posted $0.06 EPS and $150.69 million in revenue, missing estimates (consensus EPS $0.28, revenue $163.0M) and showing a negative net margin (−9.68%) and ROE (−5.13%).
• Shares traded down about 6.2% to $2.72 (market cap ~$93.2M) with a negative P/E, ~79% institutional ownership, and mixed analyst coverage (consensus "Hold" with a $12.00 target).

American Vanguard (NYSE:AVD - Get Free Report) is expected to announce its Q1 2026 results before the market opens on Monday, May 11th. Analysts expect the company to announce earnings of ($0.06) per share and revenue of $120.00 million for the quarter. Investors can find conference call details on the company's upcoming Q1 2026 earning report page for the latest details on the call scheduled for Friday, June 5, 2026 at 9:00 AM ET.

American Vanguard (NYSE:AVD - Get Free Report) last posted its earnings results on Monday, March 16th. The basic materials company reported $0.06 EPS for the quarter, missing analysts' consensus estimates of $0.28 by ($0.22). The business had revenue of $150.69 million for the quarter, compared to analysts' expectations of $163.00 million. American Vanguard had a negative net margin of 9.68% and a negative return on equity of 5.13%.

American Vanguard Stock Down 6.2%

NYSE AVD traded down $0.18 during trading on Monday, reaching $2.72. 40,765 shares of the company's stock traded hands, compared to its average volume of 298,313. The company has a debt-to-equity ratio of 0.90, a current ratio of 1.77 and a quick ratio of 0.93. The firm has a market cap of $93.15 million, a price-to-earnings ratio of -1.55 and a beta of 1.48. The company's 50 day simple moving average is $3.27 and its two-hundred day simple moving average is $4.13. American Vanguard has a 12-month low of $2.05 and a 12-month high of $5.92.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. Strs Ohio purchased a new position in shares of American Vanguard in the 1st quarter worth approximately $28,000. nVerses Capital LLC purchased a new position in shares of American Vanguard in the 4th quarter worth approximately $42,000. Virtu Financial LLC purchased a new position in shares of American Vanguard in the 4th quarter worth approximately $52,000. Jain Global LLC purchased a new position in shares of American Vanguard in the 4th quarter worth approximately $53,000. Finally, XTX Topco Ltd purchased a new position in shares of American Vanguard in the 2nd quarter worth approximately $57,000. Hedge funds and other institutional investors own 79.00% of the company's stock.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a "sell (e+)" rating on shares of American Vanguard in a research report on Wednesday, January 21st. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $12.00.

American Vanguard Company Profile

American Vanguard Corporation NYSE: AVD is a developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control. Headquartered in Newport Beach, California, the company offers a portfolio of insecticides, herbicides, fungicides and rodenticides designed for use across agricultural, turf and urban pest management applications. Its research and development efforts focus on novel chemistries and formulation technologies that address emerging pest resistance and regulatory requirements.

The company's product lines include emulsifiable concentrates, wettable powders, granular formulations, baits and liquid concentrates sold under proprietary brand names.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.